TransThera Sciences (Nanjing), Inc. (02617) released its monthly return on movements in securities for the period ending 28 February 2026. According to the announcement, the authorized share capital stood at RMB 398.99 million, comprising 303.77 million H shares listed on the Hong Kong Stock Exchange and 95.23 million unlisted shares, with no change from the previous month.

The issued share capital of TransThera Sciences (Nanjing), Inc. remained unchanged at 303.77 million H shares and 95.23 million unlisted shares. The company confirmed compliance with the 25% public float requirement, and no new share options, warrants, convertibles, or treasury share changes were reported for this period.